Public Citizen v. Food and Drug Administration (dopamine agonists)

In 2016, Public Citizen submitted a citizen petition to the Food and Drug Administration (FDA) requesting that it add stronger warnings to the labeling for dopamine agonist drugs to alert doctors and patients to the risk of impulse-control problems and compulsive behaviors, including pathological gambling, hypersexuality, compulsive shopping/spending/buying, and compulsive eating. After nearly three years passed without a substantive response from the agency, Public Citizen filed suit to compel the FDA to respond to the petition.